Oraya Therapeutics Awarded Small Business Technology Transfer Grant For Gold Nanoparticles Development
8/5/2014 10:32:25 AM
NEWARK, Calif. & BOSTON--(BUSINESS WIRE)--Oraya® Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD). Researchers believe this work could lead to a better understanding of how gold nanoparticles activated by low-energy radiation therapy can act synergistically against cancers, including difficult-to-treat cancers of the eye, without damaging healthy tissue.
Help employers find you! Check out all the jobs and post your resume.
comments powered by